2024 Patient Care Pharmaceutical Companies 
Hospital Pharmacy Europe
DECEMBER 5, 2024
2024 was a transformative year in pharmacy and therapeutics, marked by groundbreaking advances that promise lasting impacts on healthcare. Dr João Gonçalves PhD presents his pick for this year’s top five pharmacy innovations, illustrating how they set new standards for patient care and pharmaceutical development.
Hospital Pharmacy Europe
FEBRUARY 6, 2025
Conducted at Erasmus University Medical Centre in Rotterdam, Netherlands, this research developed a systematic framework known as the 8-Step Efficiency Model to identify and implement medicines cost-saving strategies while maintaining high standards of patient care. 2024 Dec 19. Reference Zietse M, et al.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Viseven
JANUARY 15, 2025
In 2024 , the top 20 pharmaceutical companies have already announced that they are actively researching uses for AI in R&D. Life sciences companies can use AI to analyze vast amounts of data and identify drug targets, design small molecules, generate synthesis pathways for chemical compounds, and predict drug properties.
Viseven
JULY 10, 2024
In an era where accurate and timely information can critically impact patient outcomes, effective communication in healthcare becomes paramount. Medical writers, thus, serve as key intermediaries between researchers, pharmaceutical companies, and the broader medical community. Scary thought, right? billion by 2032.
ISPE
SEPTEMBER 29, 2023
Takeda is the first pharmaceutical company worldwide to have implemented this water preservation project, in collaboration with a Belgian start-up Ekopak, on a large scale. NOMINATE YOUR FACILITY FOR THE 2024 FOYA PROGRAM! Register Now! Applications must be submitted by 4 December 2023.
Viseven
AUGUST 29, 2024
This marks a significant shift in patient care, as it allows for more accurate diagnoses and a better understanding of which treatments are effective and which are not, compared to relying solely on occasional hospital visits. Future Trends in 5G Network As of 2024, the 5G healthcare market is worth an earth-shattering $85 billion.
Pharmaceutical Technology
JUNE 15, 2023
Generic and biosimilar pharmaceutical company and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars. In a 15 June statement, Sandoz said that it hoped the Act4Biosimilars action plan will provide actionable solutions to overcome barriers preventing patient access to biosimilars.
Expert insights. Personalized for you.
59 
Let's personalize your content